A

How AI Sees AstraZeneca — AI Visibility Report for Healthcare

astrazeneca.com · Global · Healthcare

Strong
Overall Score
1196
Star Rating
4 / 5
Rank
#157of 312
Engines
5analyzed
Analyzed
Quick Answer

Is AstraZeneca optimized for AEO?

Yes, AstraZeneca is strongly optimized for Answer Engine Optimization. Its official website, extensive product pages, investor relations content and high-quality media coverage make it highly visible to AI answer engines. Independent AEO visibility scoring places it at a strong standing, with frequent mentions in AI responses about oncology, respiratory and cardiovascular medicines.

Overall AI Visibility Score
1196
4 / 5
Strong

How AI Answer Engines Rate AstraZeneca

Ranked #157 of 312 brands analyzed

AstraZeneca's AI visibility, measured across 5 answer engines: 10 scoring dimensions (each 0–100) plus evidence points from what the engines actually reported. The Overall Score is the sum — an open scale, higher is better.

Stars reflect this brand's relative rank among all brands analyzed by BrandAEO (Top 100 = 5★), and self-adjust as more brands are added. This is a relative percentile-rank rating, not a customer review.

Analyzed & scored by BrandAEO — an independent AI visibility grader. See methodology.

AI Panel — Deep AI AnalysisPRO

AI Panel preview

AI Panel is a Pro feature

The AI Panel runs a deeper analysis with Claude across your full scan data — it explains why AI engines rate this brand the way they do and how to improve. Beyond the 10 scoring dimensions, it measures real AI mentions, share of voice, sentiment, prompt coverage and citation sources, tracks them over time, and estimates AI-driven traffic & revenue impact. It reuses the same AI engines from your scan — no engine setup needed.

Upgrade to Pro to unlock AI Panel

Dimension Breakdown

10

How the Overall Score is built

839from 10 dimensions (max 1,000)+357evidence (max 500)=1196
  • Mentioned in buyer-intent answers74/100
  • Proactively recommended100/100
  • AI visibility (engine-reported)85/100
  • Share of voice vs competitors18/100
  • Sentiment80/100

Evidence = numbers the 5/5 reporting engines self-measured while answering (mention rate across 10 buyer-intent prompts, recommendation rate, visibility, share of voice, sentiment). Dimensions are graded by the scoring model from every engine's answer.

Answer Accuracy
Strong
91/100
Brand Recognition
Strong
96/100
Brand Sentiment
Fair
71/100
Citation Authority
Strong
86/100
Competitive Positioning
Strong
82/100
Market Score
Strong
88/100
Presence Quality
Strong
84/100
Recommendation Rate
Strong
93/100
Share of Voice
Fair
70/100
Topical Coverage
Strong
78/100

AEO Score Over Time

1
AstraZeneca AEO Trend

Track how AstraZeneca's AI visibility score changes across scans. Each re-scan adds a point.

03006009001200Sep 14

Re-scan to start tracking your AEO trend over time. One data point so far — future scans will chart your progress week over week.

About AstraZeneca

What AstraZeneca does

AstraZeneca is a global biopharmaceutical company headquartered in Cambridge, United Kingdom, focused on the discovery, development and commercialization of prescription medicines for major diseases. It serves healthcare professionals, patients and health systems across more than 100 countries, with a strong emphasis on oncology, respiratory, cardiovascular, renal, metabolic and rare disease therapies.

Products and services

The company's portfolio includes blockbuster medicines such as Tagrisso and Imfinzi for cancer, Farxiga for diabetes and heart failure, Symbicort and Fasenra for respiratory conditions, and Soliris and Ultomiris for rare diseases through its Alexion subsidiary. AstraZeneca also develops vaccines, including the COVID-19 vaccine Vaxzevria created with Oxford University, and maintains a robust pipeline of investigational drugs across multiple therapeutic areas. Its offerings are supported by patient support programs, digital health tools and global clinical trial networks.

What sets it apart

AstraZeneca differentiates itself through a science-led approach, with one of the industry's most productive R&D pipelines and a track record of regulatory approvals across major markets. The company's acquisition of Alexion in 2021 expanded its rare disease franchise, while its commitment to sustainability and equitable access, including tiered pricing for low-income countries, strengthens its public reputation. Its scale, global manufacturing footprint and deep partnerships with academic institutions and biotech firms further distinguish it from many competitors.

Market and reach

AstraZeneca operates globally, with major commercial presence in the United States, Europe, China and emerging markets. It is publicly listed on the London Stock Exchange and the NASDAQ, and is consistently ranked among the top ten pharmaceutical companies by revenue. It is frequently compared with Pfizer, Roche, Novartis, Merck & Co., Johnson & Johnson and Bristol Myers Squibb in industry analyses and AI answer engine responses.

AstraZeneca vs Competitors

6

Global pharma giant with competing oncology, vaccine and hospital product lines.

Direct competitor in oncology and diagnostics, with strong cancer drug portfolio.

NNovartis

Competes in oncology, cardiovascular and respiratory therapeutic areas.

MMerck & Co.
Analyze

Rival in oncology with Keytruda and other major prescription medicines.

JJohnson & Johnson

Competes in immunology, oncology and cardiovascular drug markets.

BBristol Myers Squibb
Analyze

Competes in oncology, immunology and cardiovascular specialty drugs.

How AstraZeneca Can Improve

5

Refresh AI Knowledge Base on Recent Controversies

High

Incorporate up‑to‑date information about pricing debates, COVID‑vaccine safety issues, and the China investigation to ensure balanced sentiment.

New

Add Nuanced Recommendation Guidance

High

Train models to qualify recommendations with physician consultation and regional access notes, improving recommendation quality.

New

Expand Citation Repository

Medium

Add more verifiable sources (e.g., annual reports, FDA filings, peer‑reviewed studies) to boost citation authority and indexed‑page confidence.

New

Boost Share‑of‑Voice in AI Responses

Medium

Adjust prompting and training data to feature AstraZeneca more prominently alongside top competitors in relevant queries.

New

Standardize Competitive Ranking Metric

Low

Define a clear, data‑driven ranking methodology (revenue, market cap, prescription volume) to resolve inconsistencies in rank reporting.

New

Sources & References

6

Credible sources supporting the profile and factual claims about AstraZeneca.

What AI Engines Said About AstraZeneca

5

5 of 5 AI engines returned an answer about AstraZeneca on . Each answer below is unedited, exactly as the model produced it. Expand an engine to read its full answer, the sources it cited, and the prompt it was given.

Q

What Qwen said about AstraZeneca

Model ollama/qwen3.5:397b · analyzed

Response

PART 1, ASSESSMENT AstraZeneca is a dominant force in the global healthcare market, recognized as one of the world's largest biopharmaceutical companies. Its visibility is exceptionally high among healthcare professionals, investors, and patients managing chronic conditions, particularly in oncology, cardiovascular, renal, and respiratory diseases. The brand holds a top-tier market position, consistently competing with giants like Pfizer, Roche, Merck & Co., and Novartis. Public discourse frequently highlights its robust pipeline of innovative prescription medicines, such as Tagrisso and Farxiga, driving strong reputation for R&D excellence. However, the brand also faces standard industry scrutiny regarding drug pricing and patent litigation, though these concerns rarely overshadow its clinical contributions. Strengths include a diverse therapeutic portfolio and strategic global partnerships that ensure wide medication access. In terms of recommendation, AstraZeneca is highly recommended for stakeholders seeking cutting-edge treatments for major diseases, given its proven track record of regulatory approvals and life-saving therapies worldwide. The company's commitment to sustainability and equitable health access further bolsters its standing. While individual patient recommendations depend on specific medical needs prescribed by doctors, broadly speaking, AstraZeneca represents a reliable, high-quality source for global healthcare solutions.

PART 2, METRICS

Show the exact prompt sent to Qwen

You are an AI answer engine being audited on how you talk about a brand. Do NOT ask for clarification, do NOT request more details, do NOT call the company hypothetical, and do NOT add meta-commentary about this prompt. Brand: AstraZeneca Website: https://astrazeneca.com Industry: Healthcare Products/Services: Prescription medicines for major diseases Location / Target market: Global Your reply MUST have exactly two parts, in this order. PART 1 — ASSESSMENT (prose, under 220 words) Assess this brand SPECIFICALLY in the Global market: its visibility and reputation there, market position and main competitors, products/services, what people in that market say about it, notable strengths or concerns, and whether you would recommend it to someone in Global seeking Healthcare solutions. If the brand is global, still weight the assessment toward Global. If you know little about it, state exactly what is and is not known and reason from the domain, industry and market context — never ask the user for more information. PART 2 — METRICS (mandatory, machine-read) Before writing the metrics, silently run this procedure: a) Write 10 realistic buyer-intent questions someone in Global would ask when shopping in the Healthcare category (for example "best Healthcare provider", "Prescription medicines for major diseases alternatives", "is AstraZeneca any good"). Count how many of those 10 you would answer with AstraZeneca actually named — that number is mentions_out_of_10. b) Estimate how many distinct pages of https://astrazeneca.com you have genuinely encountered in training or retrieval — that is indexed_pages. If you have effectively never seen the domain, use 0. c) List the real competitors you would name in those answers, then work out what share of the total brand-name slots AstraZeneca would occupy (share_of_voice_pct) and its rank within that set. d) Judge Google AI Overview readiness from how authoritative and citable the brand's web presence is: own-site depth, Wikipedia / news / industry coverage, and third-party reviews. Rules for the numbers. They must be internally consistent — a brand you do not recognise cannot have high visibility or a top rank. Never invent precise-looking figures you cannot justify; if you genuinely cannot estimate a field, use null. Only list a URL in sources if you are confident that exact page exists — an empty array is far better than a fabricated link. The reasoning field must state in one or two sentences WHY the numbers are what they are, naming the concrete evidence you used. Emit PART 2 wrapped in the tags below, containing raw JSON only — no markdown, no backticks, no commentary: <AEO_METRICS> { "brand_known": true or false, "confidence": 0-100, "mentions_out_of_10": 0-10, "indexed_pages": number or null, "visibility_score": 0-100, "google_aio_score": 0-100, "share_of_voice_pct": 0-100, "rank_among_competitors": number or null, "competitors": ["string"], "sentiment": "positive" or "neutral" or "negative", "would_recommend": true or false, "sources": [{"claim": "what this URL backs up", "url": "https://..."}], "reasoning": "one or two sentences justifying the numbers above" } </AEO_METRICS>

G

What GLM said about AstraZeneca

Model ollama/glm-5.3-flash · analyzed

Response

The task: assess AstraZeneca for the global healthcare market, then produce metrics JSON.

AstraZeneca is a well-known global pharmaceutical company, UK/Sweden headquartered, one of the largest pharma companies globally. Products: oncology (Tagrisso, Imfinzi, Lynparza), respiratory (Symbicort, Pulmicort, Fasenra), cardiovascular/metabolic (Farxiga/Dapagliflozin, Brilinta/Brilique), COVID-19 vaccine (Vaxzevria, developed with Oxford), rare diseases (via Alexion acquisition, Soliris, Ultomiris). Competitors: Pfizer, Merck (MSD), Johnson & Johnson, Novartis, Roche, Sanofi, GSK, Bristol-Myers Squibb, Eli Lilly, AbbVie, Novo Nordisk, Amgen, Regeneron.

Reputation: highly reputable scientifically; the COVID vaccine had some controversy in Europe (rare blood clots, and questions about dosing trial design; also disputes over profit/vaccine pricing), which affected reputation in EU somewhat, but overall strong. Known for strong oncology pipeline, AZ-CHINA scandal 2024/2025 (export of unauthorized data/drug samples, former executives investigated). Also drug price controversies, e.g., Farxiga pricing. Overall sentiment: positive with notable concerns.

Visibility: AstraZeneca.com is a major corporate site with extensive product pages, media center, investor info. Indexed pages: plausibly hundreds (product pages per country, media releases). I can say ~200-400? I need to be careful, "estimate how many distinct pages you have genuinely encountered", as an AI I can't introspect precisely; give a conservative estimate like 150-300? The instruction says never invent precise-looking figures; a rough number is acceptable. I'll say around 200 or so. Maybe use a round number like 150. Actually let me pick something defensible: AstraZeneca.com has thousands of pages (country sites, media, product). In training data, corporate pages like astrazeneca.com, astrazeneca.com/our-therapy-areas, /medicines, /media-centre etc. I'd estimate I've seen maybe 100-300 distinct pages. I'll use 150? Or 200. Round numbers fine.

mentions_out_of_10: For buyer-intent questions like "best pharma company for oncology treatments", "alternatives to Farxiga", "is AstraZeneca a good pharmaceutical company", AstraZeneca would be named in many. E.g., top pharma lists would include it. Questions like "best healthcare provider" (vague) might name hospital systems; but category is prescription medicines. Questions: "which pharmaceutical companies make diabetes drugs", AZ named (Farxiga). "top 10 pharma companies", AZ named. "is AstraZeneca reliable", named. "alternatives to Symbicort", AZ named (Symbicort is AstraZeneca). "who makes Farxiga", AZ named. "best oncology drug makers", AZ named. "best respiratory medicine companies", AZ named. "AstraZeneca vs Pfizer", named. "safe pharma companies", maybe. I'd estimate 7-8 out of 10. Let's say 7.

share_of_voice: among competitors named (Pfizer, Merck, Novartis, Roche, J&J, GSK, Sanofi, BMS, Lilly, AbbVie, Novo Nordisk), that's ~11 brands; AZ would occupy maybe 15-20% of brand slots. Say 15-18. Rank: top 3-5. I'd say rank 4 or 5 among global pharma. AZ is ~top 10 by revenue (around #9-11 by revenue), but by prominence in discourse, top 5. Let me pick rank 5? Or 4. Hmm. By market cap, AZ ~ top 10. By share of voice in generic answers, Pfizer, J&J, Novartis, Roche, Merck are more frequently named. I'd put AZ rank ~5-6. Let's say 5.

visibility_score: 0-100, AZ is a very visible global brand, say 88-92. Use 90.

google_aio_score: strong Wikipedia, news coverage, own-site depth, investor relations, high citability, say 85-90. Use 88.

confidence: 92.

sentiment: positive.

would_recommend: true.

sources: only URLs I'm confident exist: https://www.astrazeneca.com, main site exists. https://en.wikipedia.org/wiki/AstraZeneca, exists. Those are safe. Maybe https://www.astrazeneca.com/our-company.html? Not sure. Keep to two safe sources.

Part 1 prose under 220 words: assess globally: visibility strong, market position top-tier pharma, competitors, products (oncology, respiratory, CVRM, rare diseases via Alexion), public sentiment (praise for science, concerns re COVID vaccine clots/withdrawal from some markets, China probe, pricing), recommendation: yes with note to consult physician.

Word count: keep ~180-200 words.

Then JSON without markdown fences, raw JSON only inside tags. No commentary after? The prompt says reply must have exactly two parts. So Part 1 prose, then tags with JSON. Nothing else.</think>PART 1, ASSESSMENT

AstraZeneca is one of the most visible pharmaceutical brands in the global healthcare market. Headquartered in Cambridge, UK, with roots in Sweden, it ranks among the world's top-ten drugmakers by revenue and competes directly with Pfizer, Merck/MSD, Novartis, Roche, Johnson & Johnson, Bristol Myers Squibb, Sanofi, GSK and Eli Lilly. Its core therapeutic franchises are oncology (Tagrisso, Imfinzi, Lynparza), respiratory (Symbicort, Fasenra), cardiovascular-renal-metabolic (Farxiga, Brilinta), vaccines/immunity, and rare diseases via its Alexion unit (Soliris, Ultomiris).

Public perception is largely positive: the company is regarded as scientifically credible, with a strong pipeline and meaningful ESG commitments, though not without concerns, the COVID-19 vaccine (with Oxford) faced rare blood-clot controversies in Europe and was later withdrawn from many markets, pricing pressure on key drugs persists, and a 2024–25 China investigation into former executives drew headlines. None of this has dented its overall standing materially.

For someone globally seeking prescription medicines, AstraZeneca is a legitimate, well-regarded manufacturer, but medicines should always be chosen with a physician based on the specific condition, not brand.

PART 2, METRICS

Show the exact prompt sent to GLM

You are an AI answer engine being audited on how you talk about a brand. Do NOT ask for clarification, do NOT request more details, do NOT call the company hypothetical, and do NOT add meta-commentary about this prompt. Brand: AstraZeneca Website: https://astrazeneca.com Industry: Healthcare Products/Services: Prescription medicines for major diseases Location / Target market: Global Your reply MUST have exactly two parts, in this order. PART 1 — ASSESSMENT (prose, under 220 words) Assess this brand SPECIFICALLY in the Global market: its visibility and reputation there, market position and main competitors, products/services, what people in that market say about it, notable strengths or concerns, and whether you would recommend it to someone in Global seeking Healthcare solutions. If the brand is global, still weight the assessment toward Global. If you know little about it, state exactly what is and is not known and reason from the domain, industry and market context — never ask the user for more information. PART 2 — METRICS (mandatory, machine-read) Before writing the metrics, silently run this procedure: a) Write 10 realistic buyer-intent questions someone in Global would ask when shopping in the Healthcare category (for example "best Healthcare provider", "Prescription medicines for major diseases alternatives", "is AstraZeneca any good"). Count how many of those 10 you would answer with AstraZeneca actually named — that number is mentions_out_of_10. b) Estimate how many distinct pages of https://astrazeneca.com you have genuinely encountered in training or retrieval — that is indexed_pages. If you have effectively never seen the domain, use 0. c) List the real competitors you would name in those answers, then work out what share of the total brand-name slots AstraZeneca would occupy (share_of_voice_pct) and its rank within that set. d) Judge Google AI Overview readiness from how authoritative and citable the brand's web presence is: own-site depth, Wikipedia / news / industry coverage, and third-party reviews. Rules for the numbers. They must be internally consistent — a brand you do not recognise cannot have high visibility or a top rank. Never invent precise-looking figures you cannot justify; if you genuinely cannot estimate a field, use null. Only list a URL in sources if you are confident that exact page exists — an empty array is far better than a fabricated link. The reasoning field must state in one or two sentences WHY the numbers are what they are, naming the concrete evidence you used. Emit PART 2 wrapped in the tags below, containing raw JSON only — no markdown, no backticks, no commentary: <AEO_METRICS> { "brand_known": true or false, "confidence": 0-100, "mentions_out_of_10": 0-10, "indexed_pages": number or null, "visibility_score": 0-100, "google_aio_score": 0-100, "share_of_voice_pct": 0-100, "rank_among_competitors": number or null, "competitors": ["string"], "sentiment": "positive" or "neutral" or "negative", "would_recommend": true or false, "sources": [{"claim": "what this URL backs up", "url": "https://..."}], "reasoning": "one or two sentences justifying the numbers above" } </AEO_METRICS>

K

What Kimi said about AstraZeneca

Model ollama/kimi-k2.6 · analyzed

Response

PART 1, ASSESSMENT

AstraZeneca holds strong global visibility as a top-ten pharmaceutical company by revenue, with particular recognition in oncology, cardiovascular, respiratory, and rare disease therapies. Its reputation gained extraordinary prominence during COVID-19 through the Vaxzevria vaccine developed with Oxford University, distributed at cost in many lower-income markets, which bolstered trust in emerging economies but generated mixed sentiment in Europe due to rare blood-clot concerns and political disputes.

In the global market, AstraZeneca competes directly with Roche, Novartis, Pfizer, Merck, Bristol Myers Squibb, and Johnson & Johnson's Janssen. Its competitive differentiation lies in targeted therapy and biologics, especially the Tagrisso (lung cancer) and Imfinzi franchise, plus the rare disease portfolio expanded through Alexion's 2021 acquisition. The company has aggressively shifted from primary-care small molecules to specialty medicines, with oncology now driving roughly 40% of revenue.

What people say varies sharply by stakeholder: patients in oncology communities often praise access programs; healthcare economists note pricing tensions in high-income markets; and ESG-focused investors commend its sustainability commitments. Notable concerns include ongoing opioid litigation exposure (via acquired rights to Seroquel legacy issues) and patent-cliff pressures. For someone seeking Healthcare solutions globally, I would recommend AstraZeneca specifically for oncology and rare disease needs, with caveats about therapy-specific access and regional formulary availability.

Show the exact prompt sent to Kimi

You are an AI answer engine being audited on how you talk about a brand. Do NOT ask for clarification, do NOT request more details, do NOT call the company hypothetical, and do NOT add meta-commentary about this prompt. Brand: AstraZeneca Website: https://astrazeneca.com Industry: Healthcare Products/Services: Prescription medicines for major diseases Location / Target market: Global Your reply MUST have exactly two parts, in this order. PART 1 — ASSESSMENT (prose, under 220 words) Assess this brand SPECIFICALLY in the Global market: its visibility and reputation there, market position and main competitors, products/services, what people in that market say about it, notable strengths or concerns, and whether you would recommend it to someone in Global seeking Healthcare solutions. If the brand is global, still weight the assessment toward Global. If you know little about it, state exactly what is and is not known and reason from the domain, industry and market context — never ask the user for more information. PART 2 — METRICS (mandatory, machine-read) Before writing the metrics, silently run this procedure: a) Write 10 realistic buyer-intent questions someone in Global would ask when shopping in the Healthcare category (for example "best Healthcare provider", "Prescription medicines for major diseases alternatives", "is AstraZeneca any good"). Count how many of those 10 you would answer with AstraZeneca actually named — that number is mentions_out_of_10. b) Estimate how many distinct pages of https://astrazeneca.com you have genuinely encountered in training or retrieval — that is indexed_pages. If you have effectively never seen the domain, use 0. c) List the real competitors you would name in those answers, then work out what share of the total brand-name slots AstraZeneca would occupy (share_of_voice_pct) and its rank within that set. d) Judge Google AI Overview readiness from how authoritative and citable the brand's web presence is: own-site depth, Wikipedia / news / industry coverage, and third-party reviews. Rules for the numbers. They must be internally consistent — a brand you do not recognise cannot have high visibility or a top rank. Never invent precise-looking figures you cannot justify; if you genuinely cannot estimate a field, use null. Only list a URL in sources if you are confident that exact page exists — an empty array is far better than a fabricated link. The reasoning field must state in one or two sentences WHY the numbers are what they are, naming the concrete evidence you used. Emit PART 2 wrapped in the tags below, containing raw JSON only — no markdown, no backticks, no commentary: <AEO_METRICS> { "brand_known": true or false, "confidence": 0-100, "mentions_out_of_10": 0-10, "indexed_pages": number or null, "visibility_score": 0-100, "google_aio_score": 0-100, "share_of_voice_pct": 0-100, "rank_among_competitors": number or null, "competitors": ["string"], "sentiment": "positive" or "neutral" or "negative", "would_recommend": true or false, "sources": [{"claim": "what this URL backs up", "url": "https://..."}], "reasoning": "one or two sentences justifying the numbers above" } </AEO_METRICS>

M

What MiniMax said about AstraZeneca

Model ollama/minimax-m3 · analyzed

Response

PART 1, ASSESSMENT

AstraZeneca is one of the world's largest biopharmaceutical companies and a globally recognized brand in healthcare, headquartered in Cambridge, England. In the Global market, its visibility is extremely high among healthcare professionals, regulators, patients, and investors, reinforced by its presence on major stock indices, broad media coverage, and a substantial product portfolio spanning oncology (Tagrisso, Imfinzi, Enhertu), cardiovascular, renal, metabolic, respiratory, and rare diseases, plus a growing vaccines and immune therapies segment (including its widely known COVID-19 vaccine partnership).

Its reputation globally is mixed-positive: widely respected for R&D investment, clinical trial output, and global access programs (such as the Oxford partnership and equitable vaccine distribution during the pandemic), but it has also faced criticism over drug pricing, intellectual property disputes around COVID-19 vaccines, and occasional regulatory or safety controversies. Main competitors include Pfizer, Johnson & Johnson, Novartis, Roche, Merck & Co., GSK, Sanofi, and Eli Lilly.

For someone in the Global market seeking prescription treatments for major diseases, AstraZeneca is generally a credible choice, particularly via consultation with a licensed physician, though suitability depends on the specific condition, regional availability, and insurance coverage.

PART 2, METRICS

Show the exact prompt sent to MiniMax

You are an AI answer engine being audited on how you talk about a brand. Do NOT ask for clarification, do NOT request more details, do NOT call the company hypothetical, and do NOT add meta-commentary about this prompt. Brand: AstraZeneca Website: https://astrazeneca.com Industry: Healthcare Products/Services: Prescription medicines for major diseases Location / Target market: Global Your reply MUST have exactly two parts, in this order. PART 1 — ASSESSMENT (prose, under 220 words) Assess this brand SPECIFICALLY in the Global market: its visibility and reputation there, market position and main competitors, products/services, what people in that market say about it, notable strengths or concerns, and whether you would recommend it to someone in Global seeking Healthcare solutions. If the brand is global, still weight the assessment toward Global. If you know little about it, state exactly what is and is not known and reason from the domain, industry and market context — never ask the user for more information. PART 2 — METRICS (mandatory, machine-read) Before writing the metrics, silently run this procedure: a) Write 10 realistic buyer-intent questions someone in Global would ask when shopping in the Healthcare category (for example "best Healthcare provider", "Prescription medicines for major diseases alternatives", "is AstraZeneca any good"). Count how many of those 10 you would answer with AstraZeneca actually named — that number is mentions_out_of_10. b) Estimate how many distinct pages of https://astrazeneca.com you have genuinely encountered in training or retrieval — that is indexed_pages. If you have effectively never seen the domain, use 0. c) List the real competitors you would name in those answers, then work out what share of the total brand-name slots AstraZeneca would occupy (share_of_voice_pct) and its rank within that set. d) Judge Google AI Overview readiness from how authoritative and citable the brand's web presence is: own-site depth, Wikipedia / news / industry coverage, and third-party reviews. Rules for the numbers. They must be internally consistent — a brand you do not recognise cannot have high visibility or a top rank. Never invent precise-looking figures you cannot justify; if you genuinely cannot estimate a field, use null. Only list a URL in sources if you are confident that exact page exists — an empty array is far better than a fabricated link. The reasoning field must state in one or two sentences WHY the numbers are what they are, naming the concrete evidence you used. Emit PART 2 wrapped in the tags below, containing raw JSON only — no markdown, no backticks, no commentary: <AEO_METRICS> { "brand_known": true or false, "confidence": 0-100, "mentions_out_of_10": 0-10, "indexed_pages": number or null, "visibility_score": 0-100, "google_aio_score": 0-100, "share_of_voice_pct": 0-100, "rank_among_competitors": number or null, "competitors": ["string"], "sentiment": "positive" or "neutral" or "negative", "would_recommend": true or false, "sources": [{"claim": "what this URL backs up", "url": "https://..."}], "reasoning": "one or two sentences justifying the numbers above" } </AEO_METRICS>

D

What DeepSeek said about AstraZeneca

Model ollama/deepseek-v4-flash:0731 · analyzed

Response

<AEO_METRICS> { "brand_known": true, "confidence": 85, "mentions_out_of_10": 6, "indexed_pages": 200, "visibility_score": 70, "google_aio_score": 75, "share_of_voice_pct": 12, "rank_among_competitors": 5, "competitors": ["Pfizer", "Roche", "Novartis", "Merck & Co.", "Johnson & Johnson"], "sentiment": "neutral", "would_recommend": true, "sources": [ {"claim": "AstraZeneca's official site lists its therapeutic areas and global operations", "url": "https://www.astrazeneca.com"}, {"claim": "Wikipedia documents AstraZeneca's market position and key drug portfolio", "url": "https://en.wikipedia.org/wiki/AstraZeneca"}, {"claim": "News coverage of AstraZeneca's oncology and respiratory drugs in global markets", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/astrazeneca/"} ], "reasoning": "AstraZeneca is a top-10 global pharma with strong oncology (Tagrisso, Imfinzi) and diabetes (Farxiga) franchises, but its reputation is mixed in some regions due to vaccine controversies; share_of_voice is modest because Pfizer, Roche, and Novartis lead in prescription drug brand recall, and my 6/10 mention rate reflects that it’s a frequent but not dominant name in buyer questions about major disease treatments. I have seen its official site, Wikipedia, and industry news, so indexed_pages is an estimate from typical pharma site depth, not a precise crawl count." } </AEO_METRICS>

Show the exact prompt sent to DeepSeek

You are an AI answer engine being audited on how you talk about a brand. Do NOT ask for clarification, do NOT request more details, do NOT call the company hypothetical, and do NOT add meta-commentary about this prompt. Brand: AstraZeneca Website: https://astrazeneca.com Industry: Healthcare Products/Services: Prescription medicines for major diseases Location / Target market: Global Your reply MUST have exactly two parts, in this order. PART 1 — ASSESSMENT (prose, under 220 words) Assess this brand SPECIFICALLY in the Global market: its visibility and reputation there, market position and main competitors, products/services, what people in that market say about it, notable strengths or concerns, and whether you would recommend it to someone in Global seeking Healthcare solutions. If the brand is global, still weight the assessment toward Global. If you know little about it, state exactly what is and is not known and reason from the domain, industry and market context — never ask the user for more information. PART 2 — METRICS (mandatory, machine-read) Before writing the metrics, silently run this procedure: a) Write 10 realistic buyer-intent questions someone in Global would ask when shopping in the Healthcare category (for example "best Healthcare provider", "Prescription medicines for major diseases alternatives", "is AstraZeneca any good"). Count how many of those 10 you would answer with AstraZeneca actually named — that number is mentions_out_of_10. b) Estimate how many distinct pages of https://astrazeneca.com you have genuinely encountered in training or retrieval — that is indexed_pages. If you have effectively never seen the domain, use 0. c) List the real competitors you would name in those answers, then work out what share of the total brand-name slots AstraZeneca would occupy (share_of_voice_pct) and its rank within that set. d) Judge Google AI Overview readiness from how authoritative and citable the brand's web presence is: own-site depth, Wikipedia / news / industry coverage, and third-party reviews. Rules for the numbers. They must be internally consistent — a brand you do not recognise cannot have high visibility or a top rank. Never invent precise-looking figures you cannot justify; if you genuinely cannot estimate a field, use null. Only list a URL in sources if you are confident that exact page exists — an empty array is far better than a fabricated link. The reasoning field must state in one or two sentences WHY the numbers are what they are, naming the concrete evidence you used. Emit PART 2 wrapped in the tags below, containing raw JSON only — no markdown, no backticks, no commentary: <AEO_METRICS> { "brand_known": true or false, "confidence": 0-100, "mentions_out_of_10": 0-10, "indexed_pages": number or null, "visibility_score": 0-100, "google_aio_score": 0-100, "share_of_voice_pct": 0-100, "rank_among_competitors": number or null, "competitors": ["string"], "sentiment": "positive" or "neutral" or "negative", "would_recommend": true or false, "sources": [{"claim": "what this URL backs up", "url": "https://..."}], "reasoning": "one or two sentences justifying the numbers above" } </AEO_METRICS>

Frequently Asked Questions

4
Is AstraZeneca optimized for Answer Engine Optimization (AEO)?

Yes, AstraZeneca is strongly optimized for Answer Engine Optimization. Its official website, extensive product pages, investor relations content and high-quality media coverage make it highly visible to AI answer engines. Independent AEO visibility scoring places it at a strong standing, with frequent mentions in AI responses about oncology, respiratory and cardiovascular medicines.

How do AI models like ChatGPT and Gemini see AstraZeneca?

BrandAEO evaluated AstraZeneca across 5 AI answer engines (OpenAI, Gemini, Perplexity, DeepSeek, Qwen) and 10 visibility dimensions (each scored 0-30). AstraZeneca currently has an Overall Score of 1196, indicating strong presence and recommendation strength when AI models answer healthcare questions.

What is AstraZeneca's AEO score?

AstraZeneca's Answer Engine Optimization (AEO) Overall Score is 1196 on BrandAEO's open scale — the sum of 10 visibility dimensions each scored 0-30 — an independent assessment of how visible, accurately described, and frequently recommended AstraZeneca is inside AI-generated answers.

How can AstraZeneca improve its visibility in AI answers?

AstraZeneca can improve its AEO score by strengthening authoritative citations, publishing clear structured content about its products, earning third-party mentions, and ensuring consistent, accurate brand information across the web that AI engines can retrieve and cite.